Ongoing airway inflammation in patients with COPD who do not currently smoke

Rutgers, Steven R.; Postma, Dirkje S.; Hacken, Nick H. T. ten; Kauffman, Henk F.; van der Mark, Thomas W.; Koëter, Gerard H.; Timens, Wim
January 2000
Thorax;Jan2000, p12
Academic Journal
No abstract available.


Related Articles

  • Theophylline in COPD. Ford, P. A.; Russell, R. E. K. // General Practice Update;Jan2009, Vol. 2 Issue 1, p22 

    Chronic obstructive pulmonary disease (COPD) is forecast to reach global epidemic proportions in the next few years. There is a pressing need for new and more effective therapies, in particular ones that arrest accelerated lung function decline in patients who have stopped smoking. Due to a...

  • Smoking status and tumour necrosis factor-alpha mediated systemic inflammation in COPD patients. Tanni, Suzana E.; Pelegrino, Nilva R. G.; Angeleli, Aparecida Y. O.; Correa, Camila; Godoy, Irma // Journal of Inflammation;2010, Vol. 7, p29 

    Background: Smoking cause airway and systemic inflammation and COPD patients present low grade inflammation in peripheral blood. However, data on the influence of smoking itself on systemic inflammation in COPD patients are scarce. This study investigated the association between inflammation,...

  • Effect of Cigarette Smoke Extract on Dendritic Cells and Their Impact on T-Cell Proliferation. Mortaz, Esmaeil; Kraneveld, Aletta D.; Smit, Joost J.; Kool, Mirjam; Lambrecht, Bart N.; Kunkel, Steven L.; Lukacs, Nicholas W.; Nijkamp, Frans P.; Folkerts, Gert // PLoS ONE;2009, Vol. 4 Issue 3, p1 

    Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation. Cigarette smoke has been considered a major player in the pathogenesis of COPD. The inflamed airways of COPD patients contain several inflammatory cells including neutrophils, macrophages,T lymphocytes,...

  • Diferencias tomográficas y funcionales entre la EPOC severa relacionada con humo de leña y con cigarrillo. González-García, Mauricio; Gomez, Dario Maldonado; Torres-Duque, Carlos A.; Barrero, Margarita; Villegas, Claudia Jaramillo; Pérez, Juan Manuel; Varon, Humberto // Jornal Brasileiro de Pneumologia;mar/abr2013, Vol. 39 Issue 2, p147 

    Objective: Wood smoke exposure is a risk factor for COPD. For a given degree of airway obstruction, the reduction in DLCO is smaller in individuals with wood smoke-related COPD than in those with smoking-related COPD, suggesting that there is less emphysema in the former. The objective of this...

  • P2X7 Receptor and Caspase 1 Activation Are Central to Airway Inflammation Observed after Exposure to Tobacco Smoke. Eltom, Suffwan; Stevenson, Christopher S.; Rastrick, Joseph; Dale, Nicole; Raemdonck, Kristof; Wong, Sissie; Catley, Matthew C.; Belvisi, Maria G.; Birrell, Mark A. // PLoS ONE;2011, Vol. 6 Issue 9, p1 

    Chronic Obstructive Pulmonary Disease (COPD) is a cigarette smoke (CS)-driven inflammatory airway disease with an increasing global prevalence. Currently there is no effective medication to stop the relentless progression of this disease. It has recently been shown that an activator of the...

  • COPD management: Helping our patients breathe easier. Smoot, Laura Carter // Drug Topics;7/11/2005, Vol. 149 Issue 13, p49 

    The article discusses the management of chronic obstructive pulmonary disease (COPD). COPD is a slowly progressive lung disease characterized by a gradual loss of pulmonary function. Progressive airflow limitation is the underlying problem with COPD. Chronic inflammation of the peripheral...

  • Inflammation and Immune Response in COPD: Where Do We Stand? Rovina, Nikoletta; Koutsoukou, Antonia; Koulouris, Nikolaos G. // Mediators of Inflammation;2013, Vol. 2013, p1 

    Increasing evidence indicates that chronic inflammatory and immune responses play key roles in the development and progression of COPD. Recent data provide evidence for a role in the NLRP3 inflammasome in the airway inflammation observed in COPD. Cigarette smoke activates innate immune cells by...

  • Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD. Babusyte, Agne; Stravinskaite, Kristina; Jeroch, Jolanta; Lötvall, Jan; Sakalauskas, Raimundas; Sitkauskiene, Brigita // Respiratory Research;2007, Vol. 8, p81 

    Background: Smoking activates and recruits inflammatory cells and proteases to the airways. Matrix metalloproteinase (MMP)-12 may be a key mediator in smoke induced emphysema. However, the influence of smoking and its cessation on airway inflammation and MMP-12 expression during COPD is still...

  • From Childhood Asthma to Chronic Obstructive Pulmonary Disease: Evidence Supporting a Disease Continuum. Morton, Ronald; Eid, Nemr // Pediatric Allergy, Immunology & Pulmonology;Dec2013, Vol. 26 Issue 4, p168 

    In this review, we analyze the available evidence showing a link between asthma and chronic obstructive pulmonary disease (COPD). Many features (epidemiologic, physiologic, and histologic) overlap between these two conditions. Both environmental cigarette smoke exposure and early lung...

  • Repeatability of and Relationship between Potential COPD Biomarkers in Bronchoalveolar Lavage, Bronchial Biopsies, Serum, and Induced Sputum. Röpcke, Stefan; Holz, Olaf; Lauer, Gereon; Müller, Meike; Rittinghausen, Susanne; Ernst, Peter; Lahu, Gezim; Elmlinger, Martin; Krug, Norbert; Hohlfeld, Jens M. // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory disease, primarily affecting the airways. Stable biomarkers characterizing the inflammatory phenotype of the disease, relevant for disease activity and suited to predict disease progression are needed to monitor the efficacy...


Read the Article


Sign out of this library

Other Topics